The objectives of this study
were to determine the epidemiology and correlates of cardiovascular disease
(CVD) risk among Ugandans on first-line antiretroviral therapy (ART).
We conducted a cross-sectional study at an HIV clinic in southwestern Uganda. We enrolled adult patients on non-nucleoside-based ART regimens for a minimum of 2 years. We collected anthropometric and clinical measurements, smoking history, and blood for fasting lipid profile and blood sugar (FBS).
Outcomes of interest were
We found no independent risk factors for a Framingham risk score 10-year risk exceeding 5%, or associations between ART regimen and CVD risk profiles. We conclude that metabolic abnormalities are common among patients on first-line ART in rural Uganda, and appear to be more common in women than men.
We conducted a cross-sectional study at an HIV clinic in southwestern Uganda. We enrolled adult patients on non-nucleoside-based ART regimens for a minimum of 2 years. We collected anthropometric and clinical measurements, smoking history, and blood for fasting lipid profile and blood sugar (FBS).
Outcomes of interest were
- presence of metabolic syndrome (at least two of: FBS >100 mg/dL, blood pressure of ≥130/85 mmHg, triglycerides ≥150 mg/dL, HDL <40 mg/DL, or waist circumference ≥94 cm in males or ≥80 cm in females); and
- a Framingham score correlating to >5% 10-year CVD risk.
We found no independent risk factors for a Framingham risk score 10-year risk exceeding 5%, or associations between ART regimen and CVD risk profiles. We conclude that metabolic abnormalities are common among patients on first-line ART in rural Uganda, and appear to be more common in women than men.
Purchase full article at: http://goo.gl/KlRvdh
By: Muyanja D1, Muzoora C1, Muyingo A1, Muyindike W2, Siedner MJ3,4.
- 1 Department of Internal Medicine, Mbarara University of Science and Technology , Mbarara, Uganda .
- 2 Department of Internal Medicine, Mbarara Regional Referral Hospital , Mbarara, Uganda .
- 3 Department of Infectious Disease and Center for Global Health, Massachusetts General Hospital , Boston, Massachusetts.
- 4 Harvard Medical School , Boston, Massachusetts.
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment